News | January 24, 2024
Aster DM Healthcare gets shareholders nod to separate the GCC business
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
Collaboration streamlines patient access to oncology clinical trials
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
Beneficiaries can create Ayushman Card from their mobile phone using Ayushman App which has been downloaded 52 lakh times since its launch on 13th September, 2023
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
He is also inducted as a member of the management council and senior management personnel of the company
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
Subscribe To Our Newsletter & Stay Updated
